Analyze the relationships between the prevalence of the clinical sign follicular trachoma (TF) and the prevalence of infection and antibody to determine whether it may be appropriate to consider one or more alternative indicators for deciding whether trachoma programs can stop MDA.
Exploring alternative indicators for trachoma endpoint decision-making (Malawi)
Pgp3 seroprevalence and associations with active trachoma and ocular Chlamydia trachomatis infection in Malawi: cross-sectional surveys in six evaluation units
Sarah E. Burr, John Hart, Lyson Samikwa, David Chaima, Gretchen Cooley, Diana Martin, Michael Masika, Anthony W. Solomon, Robin L. Bailey, Khumbo Kalua
Email primary contact
Please log in or register